Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: FMCG
|Mid Cap
ZYDUSWELL
₹592
₹573.40
₹600.00
₹367.55
₹606.95
Markets Today
Historical Performance
As of 10-07-2026 18:03, Zydus Wellness Ltd. share price today is ₹0, with a change of ₹-571.50 (-100.00%) from the previous close of ₹571.5. The stock opened at ₹576.4 and traded between ₹573.4 and ₹600, with a total traded volume of 557390 shares. The company has a market capitalization of ₹18182.9 Cr in the FMCG sector. while its 52-week high and low are ₹606.95 and ₹367.55, respectively.
Zydus Wellness Ltd. valuation metrics include a P/E ratio of 92.2, EPS of ₹6.2, and book value of ₹3.10. Profitability indicators show ROE of 3.38% along with a dividend yield of 0.2%. Zydus Wellness Ltd. has reported revenue of ₹3961 Cr and net profit of ₹197.2 Cr.
Zydus Wellness Ltd. technical indicators include Day RSI at 59.95, Day MFI at 85.63, Day ADX at 32.61. Additional indicators include Commodity Channel Index (CCI) at 59.3 and Williams %R at -34.05. Momentum indicators show Day MACD at 19.9, Day MACD Signal Line at 18.02, DayATR at 23.4. Rate of Change indicators for Zydus Wellness Ltd. include ROC125 at 21.21 and ROC21 at 12.22.
Exponential moving averages include EMA5 at ₹572.1, EMA10 at ₹566.1, EMA12 at ₹562.7, EMA20 at ₹550.2, EMA26 at ₹542.8, EMA50 at ₹521.5, EMA100 at ₹494.5, EMA200 at ₹466.8. Simple moving averages include SMA5 at ₹577.7, SMA10 at ₹571.4, SMA20 at ₹542.3, SMA30 at ₹528.8, SMA50 at ₹518.4, SMA100 at ₹476.6, SMA150 at ₹461.4, SMA200 at ₹463.3.
Support levels for Zydus Wellness are placed at First Support ₹562.10, Second Support ₹552.70, Third Support ₹546.40. Resistance levels are seen at First Resistance ₹577.80, Second Resistance ₹584.10, Third Resistance ₹593.50. Zydus Wellness Ltd. shareholding pattern shows promoter holding at 69.63%, FII holding at 3.17%, DII holding at 0%, public holding at 8.32%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 132.60 | 152.60 | 156 | 87.70 | 77.50 |
| Operating Expense | 112.80 | 131.90 | 127.90 | 75.10 | 68.60 |
| Operating Profit | 19.80 | 20.70 | 28.10 | 12.60 | 8.90 |
| Depreciation | 6.30 | 6.30 | 6.40 | 1.20 | 0.90 |
| Interest | 3.10 | 3.10 | 2.50 | 2.30 | 2.10 |
| Tax | 1.90 | 2.10 | 3.90 | 2.50 | 1.50 |
| Net Profit | 13.30 | 12.10 | 7.60 | 7 | 4.70 |
₹592.00
↗ Bullish Moving Average
14
↘ Bearish Moving Average
2
Zydus Wellness Limited is a leading health and wellness products company in India, primarily engaged in the development, production, marketing, and distribution of consumer wellness products. The company operates in the FMCG sector with a portfolio spanning personal care, health supplements, and packaged foods under well-known brand names. The Zydus Wellness share price on the NSE and BSE is a reflection of how market participants respond to a performance and broader business developments within its industry. It captures the company’s sentiment of the investors based on financial results, operational updates, macroeconomic factors, and trends specific to sectors. Movements in the share price͏ reveal how the market evaluates the company’s current position and its future prospects, making ͏it a key indicator of market perception across various industries..
Market sentiment around the Zydus Wellness stock price often mirrors shifts in health awareness patterns, demand for wellness products, and investor views on the FMCG sector’s growth prospects. Factors such as the pace of new product launches, competitive intensity from other wellness players, raw material cost inflation, and government policies on food and health supplements influence near-term market valuation and medium-term earnings forecasts. All these factors must be closely monitored to have an idea about the Zydus Wellness stock price movements.
Zydus Wellness live share price provides real-time information about the last price traded, bid price, ask price, and volume traded. These indicators represent trading activity and liquidity and the reaction of investors to corporate announcements, quarterly results, and sector news. Constant monitoring of Zydus Wellness live price helps observe short-term price fluctuations and understand how the stock is moving in relation to the broader market.
Furthermore, monitoring the Zydus Wellness share price today helps investors understand real-time market sentiment, price volatility, and trading behaviour. It allows market participants to evaluate short-term performance, identify possible entry or exit points, and respond to news, quarterly results or sector trends that may affect the company’s valuation and overall investment outlook.
Zydus Wellness operates in the Indian FMCG health and wellness industry, a segment of the broader consumer goods sector. Globally, the wellness market was valued at approximately USD 1.8 trillion in 2024, with the Asia-Pacific region experiencing the fastest growth. The global functional foods and beverages market is projected to reach USD 275 billion by 2027, growing at a CAGR of 8 per cent. In India, the health supplements market was valued at USD 4.8 billion in 2024 and is expected to grow at a CAGR of 12-15 per cent through 2028. The Indian FMCG market size stood at USD 287.91 billion in 2025 and is projected to reach USD 1,150.21 billion by 2034, growing at a CAGR of 16.64 per cent. The health and wellness segment within FMCG is growing at an accelerated pace of 15-18 per cent, outpacing the broader FMCG growth of 10-12 per cent. Post-pandemic health consciousness has driven demand for immunity-boosting products and hygienic personal care items. Key challenges include raw material price volatility, intense competition from both domestic and international brands, and regulatory compliance costs. Demand is driven by rising disposable incomes, urbanisation, increased health awareness, and the growing prevalence of lifestyle diseases. The organised wellness market in India is expected to double to USD 10 billion by 2028.
Zydus Wellness Limited was incorporated in 1994. The company’s registered office is located in Ahmedabad, Gujarat. Zydus Wellness is part of the Zydus Cadila group, one of India’s prominent pharmaceutical and healthcare conglomerates. The company focuses on developing, producing, marketing, and distributing health and wellness products across India, the Middle East, and other international markets. Zydus Wellness operates in the consumer goods sector with marquee brands including Sugar Free, Everyuth, Actilife, and Nutralite. The company has played a significant role in promoting health and wellness awareness among Indian consumers through its product portfolio spanning sugar substitutes, skincare, and health supplements. Over the years, Zydus Wellness has significantly expanded its product portfolio and market presence, strengthening distribution networks across India. The company has consistently focused on product innovation and brand building to meet evolving consumer preferences. Zydus Wellness faces competition from both multinational FMCG corporations and domestic players in the wellness space, requiring continuous investment in marketing and research & development.
Zydus Wellness is actively traded on India’s principal equity markets, with its shares listed on the National Stock Exchange of India (NSE) under the symbol ZYDUSWELL and on the Bombay Stock Exchange (BSE) with the scrip code 531335. Its listing on both exchanges ensures that the Zydus Wellness price is accessible to a wide investor base, encompassing both retail and institutional market participants. The company was listed through an initial public offering in 2002. The company forms part of several benchmark indices that represent broad market segments. Zydus Wellness is included in indices such as Nifty FMCG, Nifty 500, Nifty Smallcap 100 and Nifty Mid Smallcap 400. On the BSE, the company is a constituent of indices including BSE Fast Moving Consumer Goods (FMCG), BSE 500, BSE AllCap and BSE SmallCap. Being represented in multiple indices enhances the visibility and liquidity of the Zydus Wellness price, as index tracking funds and exchange traded strategies often adjust allocations in line with constituent revisions. It also allows investors to benchmark the company’s stock performance relative to broader market trends and peer groups, facilitating cross sectional comparisons within India’s FMCG wellness landscape. The inclusion of Zydus Wellness in these indices reflects its market capitalisation and trading depth, which are key factors market participants consider when evaluating long term investment prospects and the responsiveness of the Zydus Wellness price to corporate and industry developments.
The Zydus Wellness price has exhibited moderate volatility over the past decade, shaped by the company’s leadership in India’s health and wellness sector and broader FMCG industry cycles. The Zydus Wellness price recorded a positive total return of approximately 10.25 per cent over the last 1 year and a modest positive return over longer horizons, reflecting stable performance in a defensive sector. The Zydus Wellness price delivered a 10-year total return of approximately 13.6 per cent, demonstrating consistent moderate long-term wealth creation. The Zydus Wellness share price reached a 52-week high of 552.40 and a 52-week low of 331.00, indicating a wide trading range and moderate price fluctuations reflecting typical FMCG sector stability. The Zydus Wellness price recorded a strong rally in 2020, delivering a positive annual return of 32.84 per cent, while the subsequent period has seen the Zydus Wellness share price moderate from its peak levels. The Zydus Wellness share price has shown a 1-month return of approximately 33.1 per cent and a 1-year return of 48.1 per cent, indicating strong momentum more recently.
The Zydus Wellness stock price has been particularly responsive to quarterly earnings releases and corporate announcements regarding brand performance. When the company reported steady revenue growth of 31.5 per cent in recent periods, the Zydus Wellness stock price showed positive reactions. The Zydus Wellness price has shown a pattern of stable positive momentum in years when the company’s earnings met expectations, while periods of earnings moderation or concerns over competitive pressures have contributed to consolidation in the Zydus Wellness stock price. Corporate developments, including strategic brand extensions for Sugar Free and Everyuth, have influenced medium-term fluctuations in the Zydus Wellness share price. The Zydus Wellness share price has shown a 5-year total return of approximately 4.1 per cent according to some sources, while others indicate a 5-year positive return reflecting the stock’s moderate performance. The Zydus Wellness share price has shown 10-year aggregate net profit of approximately Rs 2,017.79 crore, reflecting the company’s sustained profitability over the long term. The Zydus Wellness share price reached its 52-week high of 552.40 from its 52-week low of 331.00, reflecting the stability inherent in the FMCG wellness space. The Zydus Wellness share price has shown a year-to-date positive return, indicating continued momentum in the current fiscal year. Comprehending these patterns in the Zydus Wellness price is instrumental for investors seeking to contextualise long term performance trends.
The Zydus Wellness price has shown distinct seasonal patterns over the past decade. The Zydus Wellness share price delivered strongest annual returns of 32.84 per cent in 2020, followed by positive returns of 27.38 per cent in 2017, 19.90 per cent in 2018, and 14.06 per cent in 2024. The Zydus Wellness share price recorded negative annual returns in 2022 (-27.43 per cent), 2021 (-10.07 per cent), 2016 (-1.35 per cent), and 2013 (-5.77 per cent). The year 2026 has shown a negative return of -7.37 per cent year-to-date, indicating some near-term weakness in the current calendar year. The Zydus Wellness share price has demonstrated that the Zydus Wellness stock price tends to perform better in periods of high consumer health awareness and supportive market conditions, while underperforming during phases of economic slowdown and intense competition. The Zydus Wellness share price has shown a 10-year CAGR of 13.6 per cent, reflecting consistent long-term wealth creation.
Zydus Wellness holds a significant position for portfolio investors who seek exposure to India’s FMCG sector with a focus on the health and wellness segment. The company’s strong presence in sugar substitutes and skincare aligns it with investment strategies that value defensive consumption and the shift towards healthier lifestyles. The Zydus Wellness share price often mirrors how these themes resonate with investor portfolios, whereby both thematic and sector specific funds monitor wellness consumption indicators and brand performance when evaluating allocation decisions.
Institutional stakeholders play a significant role in Zydus Wellness’s ownership profile, with notable long term investment entities such as the Cadila Family Trust, PPFAS Mutual Fund, Nippon India Mutual Fund, Quant Mutual Fund, ICICI Prudential Mutual Fund, and HDFC Mutual Fund among key shareholders. Mutual fund holders of Zydus Wellness include PPFAS Mutual Fund – Parag Parikh Flexi Cap Fund, Nippon India Small Cap Fund, Quant Consumption Fund, Quant Healthcare Fund, ICICI Prudential Bluechip Fund, HDFC Balanced Advantage Fund, and Kotak Emerging Equity Fund. These investors represent a blend of domestic perspectives that contribute to the stock’s market liquidity and visibility within broader investment frameworks.
Based on data, the long-term beta of Zydus Wellness stands at 0.547, indicating that the Zydus Wellness share price has lower volatility than the broader market over extended periods. On a daily basis, the beta values vary, with a one-month daily range of -0.078 and a three-month daily range of 0.829, both showing very low sensitivity in short-term trading. Moving to weekly observations, the one-year weekly beta is 0.922, showing near-market sensitivity, while the two-year weekly beta is 0.942, and the two-week two-year range is 0.757, both indicating stable movements over medium-term cycles. In contrast, the monthly two-year beta stands at 1.32, highlighting modestly higher volatility and responsiveness to broader market trends in longer time frames. Supporting statistics such as mean values ranging from 351.18 to 448.26 and standard deviations from 0.941 to 9.21 further indicate limited variability in performance across periods. The Zydus Wellness share price has shown periods of responsiveness to sector-specific news and quarterly earnings releases. The Zydus Wellness stock price reflects that the company’s established brands and essential product nature provide considerable stability, though the FMCG sector remains sensitive to raw material costs and consumer sentiment.
The sector relevance of Zydus Wellness is anchored in its role within the broader Indian FMCG health and wellness industry, where it competes with other consumer goods companies. As part of this industry, the company’s strategic positioning connects wellness products to health-conscious consumers in India. Competitors in the wellness and FMCG segment include companies such as Dabur India Limited, Emami Limited, Marico Limited, Britannia Industries Limited, and Hindustan Unilever Limited (in select wellness categories). Firms with parallels in either brand portfolio or distribution scale are often referenced when evaluating relative performance within the sector.
In valuation terms, factors like the Zydus Wellness P/E ratio have shown variations over different periods. The Zydus Wellness P/E ratio stood at 30.66 times in FY 2025, 35.07 times in FY 2024, and 31.77 times in FY 2023, with the mean historical P/E ratio over recent years reflecting moderate valuations. The Zydus Wellness P/E ratio increased in 2021 to 105.73 times before adjusting to lower levels in subsequent years.
Similarly, Zydus Wellness EPS has shown consistent improvement over the past decade, reflecting the company’s stable operational performance. Zydus Wellness earnings per share have shown a trajectory of gradual growth with some fluctuations. Zydus Wellness earnings for the full year stood at Rs 346.90 crore in FY 2025, up from Rs 266.90 crore in FY 2024, representing year-on-year growth of 30 per cent. The company had reported Zydus Wellness earnings of Rs 310.40 crore in FY 2023 and Rs 308.87 crore in FY 2022, showcasing a sustained upward trend. Zydus Wellness market cap has fluctuated in line with investor perceptions of the company’s growth potential in a competitive wellness market.
Over years, the Zydus Wellness market cap has followed a pattern of moderate growth. The market cap stood at Rs 125,533 crore in FY 2021 before declining to around Rs 95,000-98,000 crore range in subsequent years, and recovering to Rs 106,364 crore in FY 2025. This movement reflects the moderate valuation zone within which the stock has traded over the analysis period.
Zydus Wellness earnings over the past five years have been characterised by consistent growth after an anomalous low in the intervening period. Net profit increased from Rs 118.73 crore in FY 2021 to Rs 308.87 crore in FY 2022, dipping slightly to Rs 310.40 crore in FY 2023 and Rs 266.90 crore in FY 2024 before rebounding to Rs 346.90 crore in FY 2025. Total revenue has grown steadily from Rs 1,875.61 crore in FY 2021 to Rs 2,722.50 crore in FY 2025, representing consistent topline expansion.
The Zydus Wellness EPS has shown variability over the past five years. The diluted EPS stood at Rs 0.38 in 2020, Rs 0.24 in 2021 and Rs 4.81 in 2022, with recent TTM EPS at Rs 45.5 reflecting significant improvement. Over a ten-year period, the company demonstrated consistent improvement in EPS after a period of lower earnings in certain years. The Zydus Wellness P/E ratio has shown fluctuations over the ten-year period. At the end of recent fiscal years, the P/E ratio has gradually declined from elevated levels, with the current P/E ratio standing at around 58.55 times compared to the historical average. The Zydus Wellness share price continues to be evaluated in the context of its earnings potential and market position, with the Wellness portfolio commanding premium valuations relative to peers in the broader FMCG sector. The Zydus Wellness stock price remains supported by the defensive nature of the wellness category and the company’s strong brand equity in key products.
Zydus Wellness is a health products company listed on both the NSE and BSE, where the Zydus Wellness share price reflects FMCG consumption trends, health awareness cycles, and brand performance within the wellness sector. Its representation in multiple stock indices supports market visibility, while investor interest is shaped by earnings stability, valuation narratives, and broader consumption themes. Within the sector, the company’s competitive context and earnings dynamics provide key perspectives on its role in India’s wellness market.
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 69.6 | 69.6 | 69.6 | 69.6 | 69.6 | 69.6 |
| FII | 3.4 | 3.3 | 3.2 | 3.4 | 3.3 | 3.2 |
| DII | 20.1 | 19.7 | 19.3 | 18.8 | 18.5 | 18.8 |
| Public | 6.9 | 7.3 | 7.8 | 8.2 | 8.5 | 8.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.24 L | 4.34 L | 51.57% |
| Week | 3.18 L | 7.43 L | 42.82% |
| 1 Month | 3.25 L | 14.62 L | 22.21% |
| 6 Month | 2.52 L | 18.54 L | 13.61% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Expensive Stars (DVM)
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 2 quarters
Increasing profits every quarter for the past 2 quarters
Companies with Zero Promoter Pledge
RSI indicating price strength
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 17 Jul, 2026 | 1.2 | FINAL | 17 Jul, 2026 | Equity Share |
| 11 Jul, 2025 | 6 | FINAL | 11 Jul, 2025 | Equity Share |
| 19 Jul, 2024 | 5 | FINAL | 19 Jul, 2024 | Equity Share |
| 21 Jul, 2023 | 5 | FINAL | 21 Jul, 2023 | Equity Share |
| 14 Jul, 2022 | 5 | FINAL | 15 Jul, 2022 | Equity Share |
| 14 Jul, 2021 | 5 | FINAL | Equity Share | |
| 19 Mar, 2020 | 5 | INTERIM | 21 Mar, 2020 | Equity Share |
| 17 Jul, 2019 | 5 | FINAL | Equity Share | |
| 18 Jul, 2018 | 8 | FINAL | Equity Share | |
| 09 Mar, 2017 | 6.5 | INTERIM | 10 Mar, 2017 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹32.89 | ₹592.55 | ₹473.90 | ₹643.05 | ₹1,120 | ₹169.63 |
| % Change | 0.55% | 0.29% | 0.49% | 0.14% | 0.02% | -0.85% |
| Revenue TTM (₹ Cr) | ₹1,030.79 | ₹2,509.14 | ₹2,391.94 | ₹2,993.86 | ₹4,125.20 | ₹2,043.56 |
| Net Profit TTM (₹ Cr) | ₹-385.64 | ₹285.67 | ₹199.94 | ₹258.26 | ₹267 | ₹140.88 |
| PE TTM | -19.90 | 28.30 | 76.90 | 62.30 | 25.30 | 37.30 |
| 1 Year Return | -18.63 | -19.06 | 56.31 | -12.6 | -21.41 | -40.91 |
| ROCE | - | 13.86 | 18.06 | 19.43 | 16.07 | 13.93 |
By signing up I certify terms, conditions & privacy policy